Entero Healthcare Solutions Limited — Investor Meet, 20-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Entero Healthcare delivered strong Q3 FY26 results: Revenue up 26% YoY to INR 1,707 Cr, with 17.1% organic growth. EBITDA increased 36% to INR 68 Cr (4% margin). Operating cash flow (OCF) hit INR 49 Cr, targeting INR 100 Cr for FY26. Net working capital days improved to 61.

Recent MedTech acquisitions now bring over INR 1,000 Cr annual revenue, expected to lift overall gross margins by 70-90 bps and EBITDA margins by 50-75 bps. The company plans to consolidate acquisitions for 2-3 quarters, focusing on integration and cash flow. Management is bullish on MedTech's organic growth and market expansion.